Novel and established anthropometric measures and the prediction of incident cardiovascular disease: A cohort study

International Journal of Obesity

Volumn 37, Issue 12, 2013, Pages 1579-1585

  Carlsson, A C ^a   Riserus U ^b   Engstrom G ^c   Arnlov J ^b,d   Melander, O ^b   Leander, K ^a   Gigante, B ^a   Hellenius M L ^e   De Faire, U ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d DALARNA UNIVERSITY   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

SAD to height ratio; sagittal abdominal diameter; Waist circumference; waist hip ratio; waist hip height ratio; WC to height ratio

Indexed keywords

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIP CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SAGITTAL ABDOMINAL DIAMETER; SAGITTAL ABDOMINAL DIAMETER TO HEIGHT RATIO; WAIST CIRCUMFERENCE; WAIST CIRCUMFERENCE TO HEIGHT RATIO; WAIST HIP HEIGHT RATIO; WAIST HIP RATIO;

BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OBESITY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SWEDEN; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84892577277     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2013.46     Document Type: Article

References (38)

1. Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases-where worlds meet. N Engl J Med 2010; 363: 1196-1198.
2. Wandell PE, Carlsson AC, Theobald H. The association between BMI value and long-term mortality. Int J Obes (Lond) 2009; 33: 577-582.
3. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984; 289: 1257-1261. (Pubitemid 15217605)
4. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984; 288: 1401-1404. (Pubitemid 14088431)
5. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649. (Pubitemid 41552419)
6. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
7. Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085-1095.
8. Riserus U, de Faire U, Berglund L, Hellenius ML. Sagittal abdominal diameter as a screening tool in clinical research: cutoffs for cardiometabolic risk. J Obes 2010; 2010: 757939.
9. Rosenblad A, Leppert J, Nilsson G. The waist-hip-height-ratio (WHHR): An improvement of the waist-hip-ratio for predicting all-cause mortality. J Diabetes 2011; 3: 1753.
10. Hadaegh F, Zabetian A, Harati H, Azizi F. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men-a 3.6-year prospective study. Exp Clin Endocrinol Diabetes 2006; 114: 310-315. (Pubitemid 44166178)
11. Petursson H, Sigurdsson JA, Bengtsson C, Nilsen TI, Getz L. Body configuration as a predictor of mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian HUNT 2 study. PLoS One 2011; 6: e26621.
12. Wandell PE, Carlsson AC, de Faire U, Hellenius ML. Prevalence of blood lipid disturbances in Swedish and foreign-born 60-year-old men and women in Stockholm, Sweden. Nutr Metab Cardiovasc Dis 2011; 21: 173-181.
13. Carlsson AC, Wandell PE, de Faire U, Hellenius ML. Risk factors associated with newly diagnosed high blood pressure in men and women. Am J Hypertens 2008; 21: 771-777. (Pubitemid 351913608)
14. Carlsson AC, Wandell PE, Halldin M, de Faire U, Hellenius ML. Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women. Metab Syndr Relat Disord 2009; 7: 231-241.
15. Carlsson AC, Wandell PE, Journath G, de Faire U, Hellenius ML. Factors associated with uncontrolled hypertension and cardiovascular risk in hypertensive 60-year-old men and women-a population-based study. Hypertens Res 2009; 32: 780-785.
16. Nordhamn K, Sodergren E, Olsson E, Karlstrom B, Vessby B, Berglund L. Reliability of anthropometric measurements in overweight and lean subjects: consequences for correlations between anthropometric and other variables. Int J Obes Relat Metab Disord 2000; 24: 652-657. (Pubitemid 30323500)
17. Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med 2000; 17: 299-307. (Pubitemid 30266125)
18. Li C, Engstrom G, Hedblad B, Calling S, Berglund G, Janzon L. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Int J Obes (Lond) 2006; 30: 1775-1781. (Pubitemid 44863410)
19. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 2009; 302: 49-57.
20. Harrell Jr FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387. (Pubitemid 26072233)
21. Kerr KF, McClelland RL, Brown ER, Lumley T. Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol 2011; 174: 364-374.
22. Tzoulaki I, Liberopoulos G, Ioannidis JP. Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol 2011; 40: 1094-1105.
23. Sundstrom J, Byberg L, Gedeborg R, Michaelsson K, Berglund L. Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination. Scand J Public Health 2011; 39: 439-441.
24. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. (Pubitemid 36712275)
25. Iribarren C, Darbinian JA, Lo JC, Fireman BH, Go AS. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol 2006; 164: 1150-1159. (Pubitemid 44950383)
26. Mukuddem-Petersen J, Snijder MB, van Dam RM, Dekker JM, Bouter LM, Stehouwer CD et al. Sagittal abdominal diameter: no advantage compared with other anthropometric measures as a correlate of components of the metabolic syndrome in elderly from the Hoorn Study. Am J Clin Nutr 2006; 84: 995-1002. (Pubitemid 44730367)
27. Bjorntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabet Med 1999; 16: 373-383.
28. Rutters F, Nieuwenhuizen AG, Lemmens SG, Bouwman F, Mariman E, Westerterp-Plantenga MS. Associations between anthropometrical measurements, body composition, single-nucleotide polymorphisms of the hypothalamus/pituitary/ adrenal (HPA) axis and HPA axis functioning. Clin Endocrinol (Oxf) 2011; 74: 679-686.
29. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108: 2317-2322. (Pubitemid 37413536)
30. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010; 42: 949-960.
31. Berg C, Rosengren A, Aires N, Lappas G, Toren K, Thelle D et al. Trends in overweight and obesity from 1985 to 2002 in Goteborg, West Sweden. Int J Obes (Lond) 2005; 29: 916-924. (Pubitemid 41076231)
32. Rosengren A, Eriksson H, Hansson PO, Svardsudd K, Wilhelmsen L, Johansson S et al. Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50. J Intern Med 2009; 266: 268-276.
33. Rosengren A, Eriksson H, Larsson B, Svardsudd K, Tibblin G, Welin L et al. Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943. J Intern Med 2000; 247: 111-118. (Pubitemid 30073171)
34. James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905-917.
35. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005; 366: 1279-1289. (Pubitemid 41416583)
36. Carlsson AC, Theobald H, Hellenius ML, Wandell PE. Cardiovascular and total mortality in men and women with different blood pressure levels-A 26-year follow-up. Blood Press 2009; 18: 105-110.
37. Journath G, Hellenius ML, Carlsson AC, Wandell PE, Nilsson PM. Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatment. Blood Press 2010; 19: 240-248.
38. Almgren T, Wilhelmsen L, Samuelsson O, Himmelmann A, Rosengren A, Andersson OK. Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. J Hypertens 2007; 25: 1311-1317. (Pubitemid 46918812)